Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Lee YL
------>authors3_c=None
------>paper_class1=1
------>Impact_Factor=None
------>paper_class3=2
------>paper_class2=1
------>vol=9
------>confirm_bywho=microbes
------>insert_bywho=yllee
------>Jurnal_Rank=None
------>authors4_c=None
------>comm_author=
------>patent_EDate=None
------>authors5_c=None
------>publish_day=None
------>paper_class2Letter=None
------>page2=465
------>medlineContent=
------>unit=E0104
------>insert_date=20040303
------>iam=1
------>update_date=None
------>author=???
------>change_event=5
------>ISSN=None
------>authors_c=None
------>score=500
------>journal_name=Human Gene Therapy
------>paper_name=Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy
------>confirm_date=20040507
------>tch_id=092064
------>pmid=9525307
------>page1=457
------>fullAbstract=It has been well demonstrated that interleukin-12 (IL-12) could be useful to defend against a variety of pathogens, to suppress tumor growth and metastasis, and even to be employed as an adjuvant of vaccines to enhance beneficial type 1 T helper (Th1) cell response over detrimental type 2 T helper (Th2) cell responses. To apply IL-12 genes in gene therapy such as a DNA vaccine, a pIL-12 vector was constructed that contained two cytomegalovirus (CMV) promoters to drive the expression of p35 and p40 subunits, respectively. In addition, a pscIL-12 vector was designed with a linker to fuse p35 cDNA with p40 cDNA to produce a single-chain IL-12 protein, ensuring not only that the expression of p35 and p40 subunits was equally expressed, but also that no free p40 subunits interfered with IL-12 activity. The data suggested pIL-12 could produce a rather high level of biologically active IL-12 after transfection of COS cell lines as well as C2C12 muscle cell lines, as measured by both concanavalin A blast proliferation assay and enzyme-linked immunosorbent assay. Interestingly, the pscIL-12 vector could also express a bioactive murine IL-12 fusion protein in vitro. Furthermore, in vivo functional studies also demonstrated that mice co-immunized with a pS vector expressing the major envelope protein of hepatitis B virus (HBV) and IL-12 vectors encoding native IL-12 or single-chain IL-12 fusion protein elicited higher levels of IgG2a anti-HBs antibody and of Th1-related cytokine. Because p35 and p40 genes can be expressed in a vector by using a single promoter, pscIL-12 should be useful in future applications for nucleic acid vaccination or for gene therapy against diseases.
------>tmu_sno=None
------>sno=8150
------>authors2=Tao MH
------>authors3=Chow YH
------>authors4=Chiang BL
------>authors5=
------>authors6=
------>authors6_c=None
------>authors=Lee YL
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=None
------>publish_area=None
------>updateTitle=Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=1998
------>submit_flag=None
------>publish_month=None
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z